4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001104659-25-005353
Chief Executive Officer acquired 90,832 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chan Phillip P. Chief Executive Officer | 2025-01-17 | Option exercise | +90,832 | $1.00 | $90,832 | 1,243,195 | D |
| Derivatives | |||||||
| Chan Phillip P. Chief Executive Officer | 2025-01-17 | Option exercise · Subscription Rights (right to buy) | −90,832 | 0 | D | ||
| Chan Phillip P. Chief Executive Officer | 2025-01-17 | Other acquisition · Series A Right Warrants | +90,832 | 90,832 | D | ||
| Chan Phillip P. Chief Executive Officer | 2025-01-17 | Other acquisition · Series B Right Warrants | +90,832 | 90,832 | D | ||
Loading xslF345X05/tm254168-4_4seq1.xml…